These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8804070)

  • 1. Nitric oxide synthesis inhibition attenuates behavioral actions of neuropeptide FF.
    Malin DH; Lake JR; Jones JA; Morel J; Moon WD; Corbit BP; Smith DA; Claunch AE; Kacher D; Stevens PA; Webb SL
    Peptides; 1996; 17(4):615-8. PubMed ID: 8804070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analog of neuropeptide FF attenuates morphine abstinence syndrome.
    Malin DH; Lake JR; Leyva JE; Hammond MV; Rogillio RB; Arcangeli KR; Ludgate K; Moore GM; Payza K
    Peptides; 1991; 12(5):1011-4. PubMed ID: 1800944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nitric oxide synthesis inhibitor nitro-L-arginine (L-NNA) attenuates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Shenoi M; Upchurch TP; Johnson SC; Schweinle WE; Cadle CD
    Psychopharmacology (Berl); 1998 Dec; 140(3):371-7. PubMed ID: 9877017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide synthase inhibition attenuates tolerance to morphine but not to [D-Ala2, Glu4] deltorphin II, a delta 2-opioid receptor agonist in mice.
    Zhao GM; Bhargava HN
    Peptides; 1996; 17(4):619-23. PubMed ID: 8804071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous injection of an analog of neuropeptide FF prevents naloxone-precipitated morphine abstinence syndrome.
    Malin DH; Lake JR; Smith DA; Jones JA; Morel J; Claunch AE; Stevens PA; Payza K; Ho KK; Liu J
    Drug Alcohol Depend; 1995 Nov; 40(1):37-42. PubMed ID: 8746922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.
    Hall S; Milne B; Jhamandas K
    Brain Res; 1996 Nov; 739(1-2):182-91. PubMed ID: 8955938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine abstinence syndrome precipitated by an analog of neuropeptide FF.
    Malin DH; Lake JR; Short PE; Blossman JB; Lawless BA; Schopen CK; Sailer EE; Burgess K; Wilson OB
    Pharmacol Biochem Behav; 1996 Jul; 54(3):581-5. PubMed ID: 8743632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome.
    Bhargava HN; Thorat SN
    Pharmacology; 1996 Feb; 52(2):86-91. PubMed ID: 8851629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between brain nitric oxide synthase activity and opiate withdrawal.
    Leza JC; Lizasoain I; Cuéllar B; Moro MA; Lorenzo P
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):349-54. PubMed ID: 8692292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide FF receptors exert contractile activity via inhibition of nitric oxide release in the mouse distal colon.
    Fang Q; Guo J; Chang M; Chen LX; Chen Q; Wang R
    Peptides; 2005 May; 26(5):791-7. PubMed ID: 15808909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous injection of an analog of neuropeptide FF precipitates morphine abstinence syndrome.
    Malin DH; Lake JR; Arcangeli KR; Deshotel KD; Hausam DD; Witherspoon WE; Carter VA; Yang HY; Pal B; Burgess K
    Life Sci; 1993; 53(17):PL261-6. PubMed ID: 8412495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of spinal nitric oxide synthase by N(omega)-nitro-L-arginine blocks the release of Met-enkephalin and antinociception induced by supraspinally administered beta-endorphin in the rat.
    Tseng LF; Wang HQ; Xu JY
    Neuroscience; 1997 May; 78(2):461-7. PubMed ID: 9145802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analog of neuropeptide FF attenuates morphine tolerance.
    Lake JR; Hebert KM; Payza K; Deshotel KD; Hausam DD; Witherspoon WE; Arcangeli KA; Malin DH
    Neurosci Lett; 1992 Nov; 146(2):203-6. PubMed ID: 1491790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide FF reduces food intake in rats.
    Murase T; Arima H; Kondo K; Oiso Y
    Peptides; 1996; 17(2):353-4. PubMed ID: 8801545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No parallel relationship between nitric oxide production and wet dog shakes susceptible to nitric oxide synthase inhibitors following systemic administration of paraquat in rats.
    Hara S; Mukai T; Kurosaki K; Kuriiwa F; Yanase T; Kano S; Endo T
    Arch Toxicol; 2001 Feb; 74(12):775-82. PubMed ID: 11305780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NO synthase inhibition modulates NMDA-induced changes in cerebral blood flow and EEG activity.
    Pelligrino DA; Gay RL; Baughman VL; Wang Q
    Am J Physiol; 1996 Sep; 271(3 Pt 2):H990-5. PubMed ID: 8853333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing interplay between Neuropeptide FF and nitric oxide in antinociception and hypothermia.
    Zajac JM; Latapie JP; Francés B
    Peptides; 2000 Aug; 21(8):1209-13. PubMed ID: 11035207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediation by nitric oxide of the carbachol-induced corticosterone secretion in rats.
    Bugajski J; Borycz J; Gadek-Michalska A; Głód R; Bugajski AJ
    J Physiol Pharmacol; 1997 Jun; 48(2):277-84. PubMed ID: 9223031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical NOS inhibition raises the lower limit of cerebral blood flow-arterial pressure autoregulation.
    Jones SC; Radinsky CR; Furlan AJ; Chyatte D; Perez-Trepichio AD
    Am J Physiol; 1999 Apr; 276(4):H1253-62. PubMed ID: 10199850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of paraquat-induced wet dog shakes by nitric oxide synthase inhibitors in rats.
    Hara S; Mukai T; Kuriiwa T; Yanase T; Kurosaki K; Kano S; Endo T
    Life Sci; 2000 Feb; 66(14):PL189-94. PubMed ID: 10755476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.